2Wei A,Juneja S. Bone marrow immunohistology of plasma cell neoplasms[J]. J Clin Pathol,2003,56(6) :406-411.
3Sukpanichnant S, Cousar JB, Leelasiri A, et al. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation[J]. Hum Pathol,1994,25(3) :308-318.
5Ng AP, Wei A, Bhurani D, et al. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells[J]. Haematologica, 2006,91 (7) : 972-975.
6Al-Ouran SZ, Yang L, Magill JM, et al. Assessment of bonemarrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistoehemistry[J]. Hum Pathol, 2007,38(12):1779-1787.
二级参考文献11
1Tai YT, Teoh G, Shima Y, et al. Isolation and characterzation of human multiple myeloma cell enriched population. J Immunol Method, 2000; 235:11-19
2Pellat-Deceunynck C, Barille S, Puthier D, et al. Adhesion molecules on human myeloma cells: signigicant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Res, 1995; 55: 3647-3653
3Garcia-Sanz R, Orfao A, Gonzalez M, et al. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy and cytogenetic characteristics. Blood, 1999; 93: 1032-1037
4Fiserova A, Hajek R, Holubova V, et al. Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells. Neoplasma, 2002; 49: 300-306
5Chilosi M, Adami F, Lestani M, et al. CD138/Syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol, 1999;12:1101-1106
6Costes V, Magen V, Legouffe E, et al. The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens. Hum Pathol, 1999; 30:1405-1411
7Almeida J, Orfao A, Mateo G, et al. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Path Biol( paris),1999; 47:119-127
8Harada H, Kawano MM, Huang N, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood, 1993; 81:2658-2663
3Paiva B, Vidriales M B, Jose J, et al. Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patient [J]. Haematologica,2009,94 (11): 1599-1602.
4Rawstron A C, Orfao A, Beksac M, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders[J]. H aematologica, 2008,93(3) :431-438.
